These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18375883)

  • 1. Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again.
    Jeremic B; Koning C
    J Clin Oncol; 2008 Apr; 26(10):e1-2. PubMed ID: 18375883
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy tripleheader extends life for non-small cell lung cancer patients. Concurrent radiation, chemotherapy and lobectomy increase survival for those with NSCLC.
    Health News; 2005 Oct; 11(10):5-6. PubMed ID: 16250091
    [No Abstract]   [Full Text] [Related]  

  • 3. New targets for the treatment of advanced non-small cell lung cancer.
    Massarelli E; Onn A; Zinner R; Khuri FR; Kim ES; Herbst RS
    Cancer Chemother Biol Response Modif; 2002; 20():717-61. PubMed ID: 12703232
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgery after induction chemoradiotherapy for non small cell lung cancer: when and why.
    Koletsis EN; Prokakis C; Apostolakis E; Chatzimichalis A; Dougenis D
    J BUON; 2007; 12(4):453-61. PubMed ID: 18067202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advanced non-small-cell lung cancer: new effective therapeutic alternatives for tomorrow?].
    Pérol M
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S20-7. PubMed ID: 15211228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Perspectives in the treatment of non-small cell lung cancer stage III with radiotherapy and concomitant low-dosage chemotherapy].
    Uitterhoeve AL; Belderbos JS; van Zandwijk N; Koning CC
    Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2709-13. PubMed ID: 19192583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?
    Langer CJ; Wakelee H; Schiller J; Choy H; Shepherd F; Vokes EE; Adjei AA; Baas P; Saijo N; Gandara DR
    Clin Lung Cancer; 2008 Mar; 9(2):85-91. PubMed ID: 18501094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiotherapy for non-small cell lung cancer].
    Girard N; Mornex F
    Rev Prat; 2009 Sep; 59(7):943-7. PubMed ID: 19839461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal survival after chemoradiation therapy for "non-bulky" stage IIIA NSCLC: what are the implications?
    Grannis FW
    Ann Thorac Surg; 2009 Apr; 87(4):1320; author reply 1320-1. PubMed ID: 19324191
    [No Abstract]   [Full Text] [Related]  

  • 11. Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: present status and future prospects.
    van Meerbeeck JP; Meersschout S; De Pauw R; Madani I; De Neve W
    Oncologist; 2008 Jun; 13(6):700-8. PubMed ID: 18586925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines update: non-small cell lung cancer.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2005 Mar; 3(2):xxix-xxx. PubMed ID: 19817021
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy].
    El Sharouni SY; Aerts JG; Senan S; De Ruysscher DK; Groen HJ; Paul MA; Smit EF; Vonk EJ; Verhagen AF; Schramel FM
    Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2714-7. PubMed ID: 19192584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.
    Kandioler D; Stamatis G; Eberhardt W; Kappel S; Zöchbauer-Müller S; Kührer I; Mittlböck M; Zwrtek R; Aigner C; Bichler C; Tichy V; Hudec M; Bachleitner T; End A; Müller MR; Roth E; Klepetko W
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1036-41. PubMed ID: 18455581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of radiotherapy and chemotherapy in locally advanced NSCLC.
    Kepka L; Sprawka A; Casas F; Abdel-Wahab S; Agarwal JP; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1389-403. PubMed ID: 19827998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of advanced non-small-cell lung cancer (take home message).
    Pirker R
    Lung Cancer; 2004 Aug; 45 Suppl 2():S259-62. PubMed ID: 15552808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer.
    Neville A
    Clin Evid; 2003 Dec; (10):1804-23. PubMed ID: 15555176
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung cancer.
    Neville A
    Clin Evid; 2005 Dec; (14):1903-20. PubMed ID: 16620475
    [No Abstract]   [Full Text] [Related]  

  • 19. Lung cancer.
    Neville A
    Clin Evid; 2004 Jun; (11):2031-53. PubMed ID: 15652095
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.
    Edelman MJ; Suntharalingam M; Burrows W; Kwong KF; Mitra N; Gamliel Z; Riley M; Cooper LB; Kennedy NL; Buskirk S; Hausner P; Doyle LA; Krasna MJ
    Ann Thorac Surg; 2008 Sep; 86(3):903-10. PubMed ID: 18721580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.